SLNO - Soleno Therapeutics receives breakthrough therapy designation from FDA for PWS treatment April, 29 2024 08:29 AM Soleno Therapeutics Inc. 2024-04-29 08:29:50 ET More on Soleno Therapeutics Soleno Therapeutics GAAP EPS of -$0.33 misses by $0.07 Seeking Alpha’s Quant Rating on Soleno Therapeutics Historical earnings data for Soleno Therapeutics Financial information for Soleno Therapeutics For further details see: Soleno Therapeutics receives breakthrough therapy designation from FDA for PWS treatment